The inhibitory effects of green tea polyphenol epigallocatechin gallate (EGCG) on virulence phenotypes and gene expression regulated by quorum sensing (QS) in Escherichia coli O157:H7 were demonstrated at concentrations of 1 to 100 g/ ml, which are lower than the MIC (539 Ϯ 22 g/ml). At 25 g/ml, the growth rate was not affected, but autoinducer 2 concentration, biofilm formation, and swarm motility decreased to 13.2, 11.8, and 50%, respectively. Survival at 5 days of nematodes (Caenorhabditis elegans) that were fed the pathogen without and with EGCG were 47.1 and 76%, respectively. Real-time PCR data indicated decreased transcriptional level in many quorum sensing-regulated virulence genes at 25 g/ml.
Bacteria use quorum sensing (QS) to regulate certain forms of gene expression by sensing their population density via hormone-like compounds, referred to as autoinducers (AI), that are excreted into the environment (16) . Escherichia coli O157:H7, a foodborne pathogen, causes hemorrhagic colitis and hemolytic uremic syndrome. E. coli O157:H7 modulates the expression of its virulence genes, including those associated with Shiga toxin (Stx), siderophore synthesis, motility, and biofilm formation, via the AI-2 signaling pathway for interspecies communication (27) (28) (29) . In patients with E. coli O157:H7 infection, antibiotic use is generally limited because the bacterial cells lysed by antibiotics are inclined to release an excessive quantity of Stx at the same time, thereby aggravating the patient's state and resulting in hemolytic uremic syndrome (32) . To risk associated with antibiotic treatment, an antipathogenic treatment that attenuates virulence without bactericidal or bacteriostatic activity has been proposed, and QS has became a popular target in the development of antipathogenic drugs (21) .
Epigallocatechin gallate (EGCG) is the most abundant polyphenolic antioxidant metabolite (catechin) in green tea. EGCG exerts bactericidal effects as well as antitoxic effects (1, 18, 24) . Green tea extract has a wide spectrum of activity against 30 different pathogenic bacteria, including strains of E. coli (7, 33, 34) . A methanol extract of green tea leaves protected Swiss white mice against mortality from Salmonella Typhimurium infection (2, 7) . The extract also is active in vitro against many gram-positive and gramnegative bacteria. The average MICs of EGCG against Staphylococcus aureus (58 Ϯ 16 g/ml) were much lower than those against Salmonella Typhimurium (496 Ϯ 15 g/ ml) and E. coli O157:H7 (539 Ϯ 22 g/ml) (7, 25) . At subinhibitory concentrations, EGCG had a synergistic effect with antibiotics against antibiotic-resistant bacteria (11, 23, 33, 36) . Although in numerous studies the synergistic effects of EGCG with a variety of antimicrobial compounds at concentrations below the MIC have been found (11, 23, 36) , there have been relatively few reports describing the individual effect on bacteria of EGCG in this concentration range. At subinhibitory concentrations, EGCG inhibited biofilm formation in ocular staphylococcal isolates (4) . EGCG also inhibited the extracellular release of Stx from E. coli O157:H7 (30) . Recently, EGCG inhibited biofilm formation and swarm motility in Pseudomonas putida and Burkholderia cepacia by interfering with the AI-1 signaling system for intraspecies communication (12) . However, neither the antipathogenic activities of EGCG in vivo nor the molecular basis underlying QS inhibition by EGCG were presented in that study.
In this study, we evaluated the potential of EGCG as an antipathogenic agent by investigating the relative changes in E. coli O157:H7 extracellular AI-2 activity, biofilm formation, swarm motility, and infection capability in the nematode Caenorhabditis elegans, a model host, in the presence of EGCG below inhibitory concentrations (5 to 100 g/ml). The temporal response of expression in QSregulated virulence genes also was investigated via realtime PCR. Our results indicate that EGCG can attenuate the virulence properties of E. coli O157:H7, particularly via the 
MATERIALS AND METHODS
EGCG. High-performance liquid chromatography grade EGCG was purchased from Sigma (St. Louis, MO).
Bacterial strains, C. elegans strain, and culture conditions. E. coli O157:H7 ATCC 43894 (American Type Culture Collection, Manassas, VA), which produces Shiga toxins I and II, and its luxS mutant were grown at 30ЊC in Luria-Bertani (LB) medium. Vibrio harveyi BB170 was grown at 30ЊC on an orbital shaker (HB-201SF, Hanbaek Scientific Technology, Bucheon City, South Korea) at 175 rpm in AB medium (9) , which consists of 0.3 M NaCl, 50 mM MgSO 4 , 0.2% (wt/vol) casamino acids, 10 mM potassium phosphate buffer (pH 7.0), 1 mM L-arginine, 2% (wt/vol) glycerol, 1 mg/liter thiamine, and 10 g/liter riboflavin. C. elegans wild-type strain N2 was obtained from the Caenorhabditis Genetics Center (University of Minnesota, St. Paul). The nematodes were maintained at 16ЊC on nematode growth medium (NGM) plates previously seeded with E. coli OP50 as a food source and were manipulated via established techniques (10).
AI-2 activity assays. The bacterial supernatants were assayed using the techniques developed by Surette and Bassler (31) . E. coli O157:H7 was grown overnight at 30ЊC in LB medium containing 0.5% (wt/vol) glucose, diluted 1:100 in the same fresh medium containing 5 to 100 g/ml EGCG, and then grown at 30ЊC. Aliquots were collected at 4 h and utilized for both optical density measurements at 600 nm (OD 600 ) and the preparation of cell-free culture fluids. The supernatant was passed through a 0.2-m-pore-size cellulose nitrate membrane filter (Whatman, Maidstone, UK). The reporter strain, V. harveyi BB170, was grown overnight in AB medium and then diluted 1:5,000 into fresh AB medium, and the cell-free supernatant from the E. coli O157:H7 was added to the diluted AB medium at a concentration of 10% (vol/vol). The luminescence values were measured with a luminescence counter (Wallac model 1450, PerkinElmer, Waltham, MA). Each experiment was conducted in triplicate.
Biofilm assay on microtiter plate. The crystal violet biofilm assay was adapted for this study (19) . E. coli O157:H7 was grown overnight at 37ЊC in M9 medium supplemented with 0.4% glucose (wt/vol) and 0.4% casamino acids (wt/vol). This culture was diluted 1:100 in the same medium containing 5 and 50 g/ml EGCG. The mixture was then transferred to polystyrene 96-well plates and incubated for 48 h at 25ЊC without shaking. To quantify the biofilm mass, the cell suspension was removed, and the plates were washed three times in water. The biofilm was then stained for 20 min with 0.1% crystal violet (wt/vol), and the extra dye was thoroughly removed with water. The remaining dye staining the biofilm was dissolved in 200 l of 95% ethanol (vol/vol), and the OD 595 was measured to quantify the biofilm mass. Each data bar represents the mean of six replicate wells, and the standard deviations were calculated.
Swarm motility assay. Tryptone broth (10 g/liter tryptone, 5 g/liter NaCl) containing 0.3% (wt/vol) agar (8) was used for the motility assays. Cultures of E. coli O157:H7 were grown overnight in liquid tryptone broth, diluted 100-fold in the same fresh medium, and grown to midexponential phase. Culture aliquots of 20 l were mixed into the same volume of EGCG solution, and the mixtures were adjusted to 5, 25, and 100 g/ml EGCG. Each tryptone plate was inoculated at the center with 5 l of each mixture, and the plate was incubated for 11 h at 30ЊC and 67% relative humidity.
RNA isolation.
To obtain RNA for identification of the genes affected by EGCG, E. coli O157:H7 was grown overnight in LB medium supplemented with 0.5% (wt/vol) glucose, diluted 1:100 in the same medium containing 25 g/l EGCG, and grown for 4 h at 30ЊC. The cells were harvested by centrifugation for 5 min at 4ЊC and 8,000 ϫ g (VS-550 centrifuge, Vision Scientific Co., Buchon City, South Korea). The total RNA was isolated using an RNeasy Lipid Tissue Mini Kit (Qiagen Inc., Valencia, CA) in accordance with the manufacturer's protocols.
Real-time quantitative RT-PCR for gene transcription analyses.
A Bioanalyzer 2100 (Agilent, Palo Alto, CA) was employed to confirm the purity and quantity of RNA in the samples. A two-step real-time quantitative reverse transcription PCR (qRT-PCR) was conducted with the RNA samples. The cDNA was prepared from 1 g of total RNA using SuperScript III First-strand Synthesis Supermix for the qRT-PCR kit (Invitrogen, Carlsbad, CA) in accordance with the manufacturer's recommendations. For the real-time qPCR, the synthesized cDNA was amplified with SYBR GreenER Universal kits (Invitrogen). The specific primers used in the real-time assays were designed with the GENETYX software package (Software Development Co., Tokyo, Japan) (Table 1). The qPCR amplification and detection were conducted on a Prism 7900 Sequence Detection System (Applied Biosystems, Foster City, CA). To analyze and quantify the gene expression data, Sequence Detection System software (SDS version 2.1, Applied Biosystems) was utilized. For standard curve plotting, a gelpurified standard DNA template representing each of the targets and the reference genes was diluted in a series from 10 10 to 10 3 copies and employed for real-time qPCR, as described above. The Growth of E. coli O157:H7 treated with various concentrations of EGCG on NGM plates. E. coli O157:H7 was grown overnight in LB broth at 30ЊC on an orbital shaker (HB-201SF, Hanbaek Scientific Technology) at 175 rpm. The serial dilutions of cultures were mixed with the same volume of EGCG solution, the mixtures were adjusted to 5, 25, and 100 g/ml EGCG, and 20 l of each mixture was dropped onto an NGM agar plate and incubated at 25ЊC. C. elegans killing assays. C. elegans killing assays were conducted as described previously but with modifications (10). All E. coli strains were grown overnight in LB broth at 37ЊC with aeration. Culture aliquots of 20 l were mixed with the same volume of EGCG solution, and the mixture was adjusted to 5, 25, and 100 g/ml EGCG and then spread onto NGM agar plates (10) . The plates were dried at 25ЊC and then immediately utilized for the assays. Twenty nematodes (N2 strain) previously synchronized at the L4 stage were transferred to each plate, incubated for 24 h at 25ЊC, and transferred to a new plate every 24 h to allow for the determination of the survival rates of the original worms without the presence of progeny. A worm was considered dead when it did not respond to being touched by a platinum wire pick. Each assay was conducted in triplicate and was repeated three times.
RESULTS AND DISCUSSION
In a previous study, EGCG at subinhibitory concentrations inhibited AI-1 signaling, swarm motility, and biofilm formation in opportunistic bacterial pathogens, including P. putida and B. cepacia (12) . These three factors have been recognized as contributing to pathogenesis in a variety of pathogenic bacteria. In the present study, we assessed the relative changes in E. coli O157:H7 extracellular AI-2 activity, biofilm formation, swarm motility, and infection capability in the nematode C. elegans, a model host, in the presence of EGCG at below inhibitory concentrations (5 to 100 g/ml). To corroborate the phenotypic changes in E. coli O157:H7 in the presence of EGCG, a real-time PCR assay was used to evaluate the changes in the expression levels of QS-regulated genes.
Decreased extracellular AI-2 concentration in culture supernatant previously grown with EGCG at subinhibitory concentrations. In previous studies, when supernatants of bacterial cultures containing a QS inhibitor such as (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone (furanone) were added to a AI-2 reporter strain V. harveyi BB170 (luxN::Tn5), the decreased levels of AI-2 were detected by the strain (22, 29) . Using this method, the inhibitory effect of EGCG on AI-2 production of E. coli O157:H7 was determined in the present study. When E. coli O157:H7 was grown in LB medium supplemented with 100 g/ml EGCG, bacterial growth was only slightly inhibited but the extracellular AI-2 concentration was significantly reduced to 6.9% (Fig. 1) in comparison with the AI-2 concentration in control cultures (0 g/ml EGCG). However, at 5 and 25 g/ml EGCG the AI-2 concentration was reduced to 40.6 and 13.2% without affecting the growth rate in a concentration-dependent manner (Fig. 1) . These results indicate that EGCG inhibits QS in E. coli O157:H7. To determine whether EGCG is an AI-2-like molecule, the AI-2 concentration in the supernatant of the ⌬luxS strain, which is unable to generate AI-2 synthase, was compared with that in the supernatant of the same strain grown with EGCG at all concentrations. With the addition of EGCG, the concentration of AI-2 did not change in the ⌬luxS strain (data not shown), thereby indicating that EGCG is not an AI-2-like molecule. 
Inhibition of biofilm formation and swarm motility.
In a previous study (21) , both swarming motility and biofilm formation of E. coli were inhibited in the presence of a QS inhibitor in a concentration-dependent manner. These results were supported by the decreased transcription levels in the genes related to biofilm formation and swarming motility via AI-2 as determined in a microarray experiment (21) . In the present study, the swarm motility and biofilm assays were performed to determine whether EGCG inhibits the bacterial properties related to AI-2 signaling. To further clarify the antipathogenic activity of EGCG against E. coli O157:H7, the effect of EGCG on biofilm formation, one of the QS-regulated phenotypes (8), was evaluated. At 5 and 25 g/ml EGCG, the biofilm formation of E. coli O157:H7 decreased to 56.4 and 11.8%, respectively, when compared with that in cultures without EGCG without affecting the growth of E. coli O157:H7 (Fig. 2) . In addition to biofilm formation, at all tested concentrations (5, 25, and 100 g/ml EGCG), swarming motility decreased 82.3, 50, and 0% in a concentration-dependent manner when compared with that in cultures without EGCG (Fig. 3) . Previous studies have generated data indicating that pathogenicity is regulated by AI-2 in many bacterial pathogens, including E. coli O157:H7. Gonzalez-Barrios et al. (8) found that synthesized AI-2 directly stimulated biofilm formation and motility in strains of E. coli. Other researchers reported that biofilm formation in Streptococcus mutans was markedly attenuated by mutation on the luxS gene as compared with biofilms formed by the wild type (35) . Similarly, Sperandio et al. (28) reported that the E. coli O157:H7 luxS mutant had reduced swarm motility and biofilm formation. Our data also suggest that the inhibitory effects of EGCG on biofilm formation and swarming motility are associated with reduced production of AI-2.
Increased survival rate of C. elegans fed E. coli O157:H7 in the presence of EGCG. C. elegans is a simple and economic invertebrate animal model that is being used increasingly for the study of mechanisms of microbial pathogenesis (17, 26) . C. elegans was reported to be a good model to evaluate the virulence of E. coli O157:H7 and the antibacterial effectiveness of many types of chemical compounds (5, 15) . C. elegans fed a nonpathogenic E. coli strain (OP50) lived longer than C. elegans fed E. coli O157: H7. In this study, C. elegans killing assays were conducted to determine whether EGCG could attenuate the virulence of E. coli O157:H7, thus protecting C. elegans fed on this microorganism from E. coli O157:H7 infection. The growth of E. coli O157:H7 on NGM plates was not affected in the presence of EGCG at concentrations of 5 to 100 g/ml (Fig. 4 ). There were no significant differences in the survival rates of C. elegans for 4 days, but at 5 days the survival rate for the nematodes fed only E. coli O157:H7 were significantly lower than those for nematodes fed the pathogen in the presence of EGCG (Fig. 5) . The attenuation of bacterial virulence by EGCG was dependent on its concentration. Survival rates of the nematodes for 5 days were 64, 76, and 86% fed E. coli O157:H7 cultures with 5, 25, and 100 g/ml EGCG, respectively. Rasmussen et al. (20) found that a QS mutant of Pseudomonas aeruginosa killed fewer nematodes than did the wild-type strain. Kim et al. (14) also found that E. coli O157:H7 in the presence of exogenous AI-2 molecules killed more nematodes than it did in the absence of the AI-2 molecules. Brown et al. (6) reported that the life span of C. elegans fed a nonpatho- genic E. coli OP50 with EGCG was similar to that of C. elegans fed only E. coli OP50. The results of our C. elegans killing assay suggest that EGCG can protect the nematodes against pathogenic attack by inhibiting QS.
EGCG reduces the transcription of major virulence genes in E. coli O157:H7. To determine whether reduced AI-2 activity induced by EGCG also can reduce the expression of virulence genes regulated by QS, RT-PCR assays were conducted. The transcription levels of the eae, escN, espA, sepZ, and tir genes in the locus for enterocyte effacement (LEE)-encoded type III secretion system (TTSS) decreased to 72.1, 87.3, 79.5, 78.8, and 90.8%, respectively, when grown with 25 g/ml EGCG (Fig. 6) . The reduced transcription levels were correlated with the reduction in the transcription level of qseA, the activator of the LEE-encoded virulence genes (Fig. 6 ). E. coli O157:H7 induces a characteristic histopathology in intestinal cells, known as attaching and effacing (A/E). The A/E phenotypes are encoded by the LEE pathogenicity island (13) . The LEE pathogenicity island harbors (i) the sep and esc genes encoding for a TTSS, (ii) the eae gene for the adhesin intimin, (iii) the espABD genes for proteins secreted by the TTSS, and (iv) the tir gene for the translocated intimin receptor. These genes in the LEE island are activated by the transcription of the qseA gene, which is activated by QS via AI-2 molecules (27, 29) .
The transcription levels in the qseB and qseC genes also were decreased to 40.5 and 40.5% in the presence of EGCG (Fig. 6) . This reduced transcription level appeared to affect the transcription of flhD, which was reduced to 48.6%. QS also activates the expression of genes involved in the assembly of flagella and motility via the activation of flhDC transcription (29) . In a previous study, experiments revealed that E. coli O157:H7 required flagella for the persistent colonization of chickens (3) .
Transcription of the genes associated with production of Shiga toxin (stx 1 B and stx 2 B) decreased to 38.8 and 58.1% in the presence of EGCG (Fig. 6 ). Other researchers reported that 50 to 200 g/ml EGCG gradually inhibited the extracellular release of Stx from E. coli O157:H7 (30). Sperandio et al. (28) also observed a threefold reduction in stx transcription in the luxS mutant compared with the stx transcription in the wild-type strain. Our data indicate that EGCG can reduce Stx production.
Collectively, the results of our RT-PCR assays demonstrate that transcription of the genes encoding for major QS-regulated virulence factors was reduced in the presence of EGCG, thereby suggesting that EGCG interferes with AI-2 signaling.
In this study, EGCG was capable of interfering with QS in enterohemorrhagic E. coli O157:H7 by decreasing AI-2 production. In the presence of EGCG, extracellular AI-2 concentration, exopolysaccharide production, swarm motility, and virulence in E. coli O157:H7 were reduced. These phenotypic changes in E. coli O157:H7 in the presence of EGCG were supported by the results of our RT-PCR assay. Our results indicate that EGCG is a QS inhibitor that can be utilized as an antipathogenic agent for the prevention of E. coli O157:H7 infection and that EGCG also may attenuate virulence in other QS pathogens. In cases of E. coli O157:H7 infection, EGCG could be utilized in an alternative treatment regimen for those patients whose symptoms could be aggravated by antibiotic use.
